HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of sphingosine-1-phosphate on the endothelial glycocalyx during ischemia-reperfusion injury in the isolated rat heart.

AbstractOBJECTIVE:
Sphingosine-1-phosphate is a natural metabolite that is cardioprotective, but its effects on endothelial glycocalyx damage during ischemia-reperfusion are unknown. Therefore, we investigated the effect of sphingosine-1-phosphate on the endothelial glycocalyx during ischemia-reperfusion.
METHODS:
Isolated hearts from Wistar rats were perfused on a Langendorff system with Krebs-Henseleit buffer and pretreated with sphingosine-1-phosphate (10 nmol/L) before ischemia-reperfusion. Infarct size was measured by triphenyl tetrazolium chloride staining (n ≥ 6 per group). Cardiac edema was assessed by calculating total water content (n = 7 per group) and histologically quantifying the interstitial compartment (n ≥ 3 per group). The post-ischemic coronary release of syndecan-1 was quantified using ELISA. Syndecan-1 immunostaining intensity was assessed in perfusion-fixed hearts (n ≥ 3 per group).
RESULTS:
Pretreatment with sphingosine-1-phosphate decreased infarct size in isolated hearts subjected to ischemia-reperfusion (P = .01 vs ischemia-reperfusion). However, sphingosine-1-phosphate had no effect on syndecan-1 levels in the coronary effluent or on the intensity of the syndecan-1 immunostaining signal in cardiac tissue. Heart total water content was not significantly different between control and ischemic groups but was significantly decreased in hearts treated with sphingosine-1-phosphate alone.
CONCLUSION:
These results suggest that sphingosine-1-phosphate-induced cardioprotection against ischemia-reperfusion injury is not mediated by the maintenance of syndecan-1 in the endothelial glycocalyx.
AuthorsHala Araibi, Elizabeth van der Merwe, Asfree Gwanyanya, Roisin Kelly-Laubscher
JournalMicrocirculation (New York, N.Y. : 1994) (Microcirculation) Vol. 27 Issue 5 Pg. e12612 (07 2020) ISSN: 1549-8719 [Electronic] United States
PMID32017300 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2020 John Wiley & Sons Ltd.
Chemical References
  • Lysophospholipids
  • Syndecan-1
  • sphingosine 1-phosphate
  • Sphingosine
Topics
  • Animals
  • Endothelium, Vascular (metabolism, pathology)
  • Glycocalyx (metabolism, pathology)
  • Lysophospholipids (metabolism, pharmacology)
  • Male
  • Myocardial Reperfusion Injury (metabolism, pathology)
  • Myocardium (metabolism, pathology)
  • Rats
  • Rats, Wistar
  • Sphingosine (analogs & derivatives, metabolism, pharmacology)
  • Syndecan-1 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: